Skip to main content
Top
Published in: Inflammation 2/2024

Open Access 17-11-2023 | Acetylcysteine | RESEARCH

The Effect of Glycine and N-Acetylcysteine on Oxidative Stress in the Spinal Cord and Skeletal Muscle After Spinal Cord Injury

Authors: Xin Xu, Chun-Jia Zhang, Zuliyaer Talifu, Wu-Bo Liu, Ze-Hui Li, Xiao-Xin Wang, Hua-Yong Du, Han Ke, De-Gang Yang, Feng Gao, Liang-Jie Du, Yan Yu, Ying-Li Jing, Jian-Jun Li

Published in: Inflammation | Issue 2/2024

Login to get access

Abstract

Oxidative stress is a frequently occurring pathophysiological feature of spinal cord injury (SCI) and can result in secondary injury to the spinal cord and skeletal muscle atrophy. Studies have reported that glycine and N-acetylcysteine (GlyNAC) have anti-aging and anti-oxidative stress properties; however, to date, no study has assessed the effect of GlyNAC in the treatment of SCI. In the present work, we established a rat model of SCI and then administered GlyNAC to the animals by gavage at a dose of 200 mg/kg for four consecutive weeks. The BBB scores of the rats were significantly elevated from the first to the eighth week after GlyNAC intervention, suggesting that GlyNAC promoted the recovery of motor function; it also promoted the significant recovery of body weight of the rats. Meanwhile, the 4-week heat pain results also suggested that GlyNAC intervention could promote the recovery of sensory function in rats to some extent. Additionally, after 4 weeks, the levels of glutathione and superoxide dismutase in spinal cord tissues were significantly elevated, whereas that of malondialdehyde was significantly decreased in GlyNAC-treated animals. The gastrocnemius wet weight ratio and total antioxidant capacity were also significantly increased. After 8 weeks, the malondialdehyde level had decreased significantly in spinal cord tissue, while reactive oxygen species accumulation in skeletal muscle had decreased. These findings suggested that GlyNAC can protect spinal cord tissue, delay skeletal muscle atrophy, and promote functional recovery in rats after SCI.
Literature
3.
go back to reference Zhao, W., N. Gasterich, T. Clarner, et al. 2022. Astrocytic Nrf2 expression protects spinal cord from oxidative stress following spinal cord injury in a male mouse model. Journal of Neuroinflammation 19 (1): 134.PubMedPubMedCentralCrossRef Zhao, W., N. Gasterich, T. Clarner, et al. 2022. Astrocytic Nrf2 expression protects spinal cord from oxidative stress following spinal cord injury in a male mouse model. Journal of Neuroinflammation 19 (1): 134.PubMedPubMedCentralCrossRef
4.
go back to reference Scheijen, E.E.M., S. Hendrix, and D.M. Wilson 3rd. 2022. Oxidative DNA damage in the pathophysiology of spinal cord injury: seems obvious, but where is the evidence? Antioxidants 11 (9): 1728.PubMedPubMedCentralCrossRef Scheijen, E.E.M., S. Hendrix, and D.M. Wilson 3rd. 2022. Oxidative DNA damage in the pathophysiology of spinal cord injury: seems obvious, but where is the evidence? Antioxidants 11 (9): 1728.PubMedPubMedCentralCrossRef
5.
go back to reference Fatima, G., V.P. Sharma, S.K. Das, et al. 2015. Oxidative stress and antioxidative parameters in patients with spinal cord injury: implications in the pathogenesis of disease. Spinal Cord 53 (1): 3–6.PubMedCrossRef Fatima, G., V.P. Sharma, S.K. Das, et al. 2015. Oxidative stress and antioxidative parameters in patients with spinal cord injury: implications in the pathogenesis of disease. Spinal Cord 53 (1): 3–6.PubMedCrossRef
6.
go back to reference Graham, Z.A., L. Collier, Y. Peng, et al. 2016. A soluble activin receptor IIB fails to prevent muscle atrophy in a mouse model of spinal cord injury. Journal of Neurotrauma 33 (12): 1128–1135.PubMedCrossRef Graham, Z.A., L. Collier, Y. Peng, et al. 2016. A soluble activin receptor IIB fails to prevent muscle atrophy in a mouse model of spinal cord injury. Journal of Neurotrauma 33 (12): 1128–1135.PubMedCrossRef
7.
go back to reference Xu, X., Z. Talifu, C.J. Zhang, et al. 2023. Mechanism of skeletal muscle atrophy after spinal cord injury: a narrative review. Frontiers in Nutrition 10: 1099143.PubMedPubMedCentralCrossRef Xu, X., Z. Talifu, C.J. Zhang, et al. 2023. Mechanism of skeletal muscle atrophy after spinal cord injury: a narrative review. Frontiers in Nutrition 10: 1099143.PubMedPubMedCentralCrossRef
8.
go back to reference Yin, L., N. Li, W. Jia, et al. 2021. Skeletal muscle atrophy: from mechanisms to treatments. Pharmacological Research 172: 105807.PubMedCrossRef Yin, L., N. Li, W. Jia, et al. 2021. Skeletal muscle atrophy: from mechanisms to treatments. Pharmacological Research 172: 105807.PubMedCrossRef
9.
go back to reference Wang, D., Y. Yang, X. Zou, et al. 2020. Antioxidant apigenin relieves age-related muscle atrophy by inhibiting oxidative stress and hyperactive mitophagy and apoptosis in skeletal muscle of mice. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 75 (11): 2081–2088.PubMedCrossRef Wang, D., Y. Yang, X. Zou, et al. 2020. Antioxidant apigenin relieves age-related muscle atrophy by inhibiting oxidative stress and hyperactive mitophagy and apoptosis in skeletal muscle of mice. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 75 (11): 2081–2088.PubMedCrossRef
11.
go back to reference Margaritelis, N.V., P.N. Chatzinikolaou, F.V. Bousiou, et al. 2021. Dietary cysteine intake is associated with blood glutathione levels and isometric strength. International Journal of Sports Medicine 42 (5): 441–447.PubMedCrossRef Margaritelis, N.V., P.N. Chatzinikolaou, F.V. Bousiou, et al. 2021. Dietary cysteine intake is associated with blood glutathione levels and isometric strength. International Journal of Sports Medicine 42 (5): 441–447.PubMedCrossRef
12.
go back to reference Patel, S.P., P.G. Sullivan, J.D. Pandya, et al. 2014. N-acetylcysteine amide preserves mitochondrial bioenergetics and improves functional recovery following spinal trauma. Experimental Neurology 257: 95–105.PubMedPubMedCentralCrossRef Patel, S.P., P.G. Sullivan, J.D. Pandya, et al. 2014. N-acetylcysteine amide preserves mitochondrial bioenergetics and improves functional recovery following spinal trauma. Experimental Neurology 257: 95–105.PubMedPubMedCentralCrossRef
13.
go back to reference Xu, G.Y., M.G. Hughes, Z. Ye, et al. 2004. Concentrations of glutamate released following spinal cord injury kill oligodendrocytes in the spinal cord. Experimental Neurology 187 (2): 329–336.PubMedCrossRef Xu, G.Y., M.G. Hughes, Z. Ye, et al. 2004. Concentrations of glutamate released following spinal cord injury kill oligodendrocytes in the spinal cord. Experimental Neurology 187 (2): 329–336.PubMedCrossRef
14.
go back to reference Miyazato, M., K. Sugaya, S. Nishijima, et al. 2003. Inhibitory effect of intrathecal glycine on the micturition reflex in normal and spinal cord injury rats. Experimental Neurology 183 (1): 232–240.PubMedCrossRef Miyazato, M., K. Sugaya, S. Nishijima, et al. 2003. Inhibitory effect of intrathecal glycine on the micturition reflex in normal and spinal cord injury rats. Experimental Neurology 183 (1): 232–240.PubMedCrossRef
15.
go back to reference Li, Q.S., and Y.J. Jia. 2023. Ferroptosis: a critical player and potential therapeutic target in traumatic brain injury and spinal cord injury. Neural Regeneration Research 18 (3): 506–512.PubMedCrossRef Li, Q.S., and Y.J. Jia. 2023. Ferroptosis: a critical player and potential therapeutic target in traumatic brain injury and spinal cord injury. Neural Regeneration Research 18 (3): 506–512.PubMedCrossRef
16.
go back to reference Kumar, P., C. Liu, J. Suliburk, et al. 2023. Supplementing glycine and N-acetylcysteine (GlyNAC) in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, physical function, and aging hallmarks: a randomized clinical trial. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 78 (1): 75–89.PubMedCrossRef Kumar, P., C. Liu, J. Suliburk, et al. 2023. Supplementing glycine and N-acetylcysteine (GlyNAC) in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, physical function, and aging hallmarks: a randomized clinical trial. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 78 (1): 75–89.PubMedCrossRef
17.
go back to reference Weinberg, J.M., A. Bienholz, and M.A. Venkatachalam. 2016. The role of glycine in regulated cell death. Cellular and Molecular Life Sciences 73 (11–12): 2285–2308.PubMedCrossRef Weinberg, J.M., A. Bienholz, and M.A. Venkatachalam. 2016. The role of glycine in regulated cell death. Cellular and Molecular Life Sciences 73 (11–12): 2285–2308.PubMedCrossRef
18.
go back to reference Ascher, E., J.N. Hanson, W. Cheng, et al. 2001. Glycine preserves function and decreases necrosis in skeletal muscle undergoing ischemia and reperfusion injury. Surgery 129 (2): 231–235.PubMedCrossRef Ascher, E., J.N. Hanson, W. Cheng, et al. 2001. Glycine preserves function and decreases necrosis in skeletal muscle undergoing ischemia and reperfusion injury. Surgery 129 (2): 231–235.PubMedCrossRef
19.
go back to reference Koopman, R., M.K. Caldow, D.J. Ham, et al. 2017. Glycine metabolism in skeletal muscle: implications for metabolic homeostasis. Current Opinion in Clinical Nutrition and Metabolic Care 20 (4): 237–242.PubMedCrossRef Koopman, R., M.K. Caldow, D.J. Ham, et al. 2017. Glycine metabolism in skeletal muscle: implications for metabolic homeostasis. Current Opinion in Clinical Nutrition and Metabolic Care 20 (4): 237–242.PubMedCrossRef
20.
go back to reference Nishijima, S., K. Sugaya, M. Miyazato, et al. 2003. Changes of bladder activity and glycine levels in the spinal cord and serum after spinal cord injury in rats. Biomedical Research 24 (4): 165–171.CrossRef Nishijima, S., K. Sugaya, M. Miyazato, et al. 2003. Changes of bladder activity and glycine levels in the spinal cord and serum after spinal cord injury in rats. Biomedical Research 24 (4): 165–171.CrossRef
21.
go back to reference Ham, D.J., M.K. Caldow, V. Chhen, et al. 2016. Glycine restores the anabolic response to leucine in a mouse model of acute inflammation. American Journal of Physiology. Endocrinology and Metabolism 310 (11): E970–E981.PubMedCrossRef Ham, D.J., M.K. Caldow, V. Chhen, et al. 2016. Glycine restores the anabolic response to leucine in a mouse model of acute inflammation. American Journal of Physiology. Endocrinology and Metabolism 310 (11): E970–E981.PubMedCrossRef
22.
go back to reference Kinoshita, H., S. Orita, K. Inage, et al. 2019. Skeletal muscle cell oxidative stress as a possible therapeutic target in a denervation-induced experimental sarcopenic model. Spine 44 (8): E446–E455.PubMedCrossRef Kinoshita, H., S. Orita, K. Inage, et al. 2019. Skeletal muscle cell oxidative stress as a possible therapeutic target in a denervation-induced experimental sarcopenic model. Spine 44 (8): E446–E455.PubMedCrossRef
23.
go back to reference Baltzer, W.I., M.A. McMichael, G.L. Hosgood, et al. 2008. Randomized, blinded, placebo-controlled clinical trial of N-acetylcysteine in dogs with spinal cord trauma from acute intervertebral disc disease. Spine 33 (13): 1397–1402.PubMedCrossRef Baltzer, W.I., M.A. McMichael, G.L. Hosgood, et al. 2008. Randomized, blinded, placebo-controlled clinical trial of N-acetylcysteine in dogs with spinal cord trauma from acute intervertebral disc disease. Spine 33 (13): 1397–1402.PubMedCrossRef
24.
go back to reference Changchien, C.Y., Y.H. Lin, Y.C. Cheng, et al. 2019. Indoxyl sulfate induces myotube atrophy by ROS-ERK and JNK-MAFbx cascades. Chemico-Biological Interactions 304: 43–51.PubMedCrossRef Changchien, C.Y., Y.H. Lin, Y.C. Cheng, et al. 2019. Indoxyl sulfate induces myotube atrophy by ROS-ERK and JNK-MAFbx cascades. Chemico-Biological Interactions 304: 43–51.PubMedCrossRef
25.
go back to reference Sekhar, R.V., S.G. Patel, A.P. Guthikonda, et al. 2011. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. American Journal of Clinical Nutrition 94 (3): 847–853.PubMedPubMedCentralCrossRef Sekhar, R.V., S.G. Patel, A.P. Guthikonda, et al. 2011. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. American Journal of Clinical Nutrition 94 (3): 847–853.PubMedPubMedCentralCrossRef
26.
go back to reference McCarty, M.F., J.H. O’Keefe, and J.J. DiNicolantonio. 2018. Dietary glycine is rate-limiting for glutathione synthesis and may have broad potential for health protection. The Ochsner Journal 18 (1): 81–87.PubMedPubMedCentral McCarty, M.F., J.H. O’Keefe, and J.J. DiNicolantonio. 2018. Dietary glycine is rate-limiting for glutathione synthesis and may have broad potential for health protection. The Ochsner Journal 18 (1): 81–87.PubMedPubMedCentral
28.
go back to reference Kumar, P., C. Liu, J.W. Hsu, et al. 2021. Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: results of a pilot clinical trial. Clinical and Translational Medicine 11 (3): e372.PubMedPubMedCentralCrossRef Kumar, P., C. Liu, J.W. Hsu, et al. 2021. Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: results of a pilot clinical trial. Clinical and Translational Medicine 11 (3): e372.PubMedPubMedCentralCrossRef
29.
go back to reference Sekhar, R.V. 2022. GlyNAC (glycine and N-acetylcysteine) supplementation improves impaired mitochondrial fuel oxidation and lowers insulin resistance in patients with type 2 diabetes: results of a pilot study. Antioxidants 11 (1): 154.PubMedPubMedCentralCrossRef Sekhar, R.V. 2022. GlyNAC (glycine and N-acetylcysteine) supplementation improves impaired mitochondrial fuel oxidation and lowers insulin resistance in patients with type 2 diabetes: results of a pilot study. Antioxidants 11 (1): 154.PubMedPubMedCentralCrossRef
30.
go back to reference Kumar, P., O.W. Osahon, and R.V. Sekhar. 2023. GlyNAC (glycine and N-acetylcysteine) supplementation in old mice improves brain glutathione deficiency, oxidative stress, glucose uptake, mitochondrial dysfunction, genomic damage, inflammation and neurotrophic factors to reverse age-associated cognitive decline: implications for improving brain health in aging. Antioxidants 12 (5): 1042.PubMedPubMedCentralCrossRef Kumar, P., O.W. Osahon, and R.V. Sekhar. 2023. GlyNAC (glycine and N-acetylcysteine) supplementation in old mice improves brain glutathione deficiency, oxidative stress, glucose uptake, mitochondrial dysfunction, genomic damage, inflammation and neurotrophic factors to reverse age-associated cognitive decline: implications for improving brain health in aging. Antioxidants 12 (5): 1042.PubMedPubMedCentralCrossRef
31.
go back to reference Ge, X., P. Tang, Y. Rong, et al. 2021. Exosomal miR-155 from M1-polarized macrophages promotes EndoMT and impairs mitochondrial function via activating NF-κB signaling pathway in vascular endothelial cells after traumatic spinal cord injury. Redox Biology 41: 101932.PubMedPubMedCentralCrossRef Ge, X., P. Tang, Y. Rong, et al. 2021. Exosomal miR-155 from M1-polarized macrophages promotes EndoMT and impairs mitochondrial function via activating NF-κB signaling pathway in vascular endothelial cells after traumatic spinal cord injury. Redox Biology 41: 101932.PubMedPubMedCentralCrossRef
32.
go back to reference Springer, J.E., R.R. Rao, H.R. Lim, et al. 2010. The functional and neuroprotective actions of Neu 2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury. Journal of Neurotrauma 27 (1): 139–149.PubMedPubMedCentralCrossRef Springer, J.E., R.R. Rao, H.R. Lim, et al. 2010. The functional and neuroprotective actions of Neu 2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury. Journal of Neurotrauma 27 (1): 139–149.PubMedPubMedCentralCrossRef
33.
go back to reference Bains, M., and E.D. Hall. 2012. Antioxidant therapies in traumatic brain and spinal cord injury. Biochimica et Biophysica Acta 1822 (5): 675–684.PubMedCrossRef Bains, M., and E.D. Hall. 2012. Antioxidant therapies in traumatic brain and spinal cord injury. Biochimica et Biophysica Acta 1822 (5): 675–684.PubMedCrossRef
34.
go back to reference Lee, Y.S., D.C. Cho, C.H. Kim, et al. 2019. Effect of curcumin on the inflammatory reaction and functional recovery after spinal cord injury in a hyperglycemic rat model. The Spine Journal 19 (12): 2025–2039.PubMedCrossRef Lee, Y.S., D.C. Cho, C.H. Kim, et al. 2019. Effect of curcumin on the inflammatory reaction and functional recovery after spinal cord injury in a hyperglycemic rat model. The Spine Journal 19 (12): 2025–2039.PubMedCrossRef
35.
go back to reference Nukolova, N.V., A.D. Aleksashkin, T.O. Abakumova, et al. 2018. Multilayer polyion complex nanoformulations of superoxide dismutase 1 for acute spinal cord injury. Journal of Controlled Release 270: 226–236.PubMedCrossRef Nukolova, N.V., A.D. Aleksashkin, T.O. Abakumova, et al. 2018. Multilayer polyion complex nanoformulations of superoxide dismutase 1 for acute spinal cord injury. Journal of Controlled Release 270: 226–236.PubMedCrossRef
36.
go back to reference Reddy, M.K., and V. Labhasetwar. 2009. Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. The FASEB Journal 23 (5): 1384–1395.PubMedCrossRef Reddy, M.K., and V. Labhasetwar. 2009. Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. The FASEB Journal 23 (5): 1384–1395.PubMedCrossRef
37.
go back to reference Gorgey, A.S., and G.A. Dudley. 2007. Skeletal muscle atrophy and increased intramuscular fat after incomplete spinal cord injury. Spinal Cord 45 (4): 304–309.PubMedCrossRef Gorgey, A.S., and G.A. Dudley. 2007. Skeletal muscle atrophy and increased intramuscular fat after incomplete spinal cord injury. Spinal Cord 45 (4): 304–309.PubMedCrossRef
38.
39.
go back to reference Savikj, M., E. Kostovski, L.S. Lundell, et al. 2019. Altered oxidative stress and antioxidant defence in skeletal muscle during the first year following spinal cord injury. Physiological Reports 7 (16): e14218.PubMedPubMedCentralCrossRef Savikj, M., E. Kostovski, L.S. Lundell, et al. 2019. Altered oxidative stress and antioxidant defence in skeletal muscle during the first year following spinal cord injury. Physiological Reports 7 (16): e14218.PubMedPubMedCentralCrossRef
40.
go back to reference Smuder, A.J., S.M. Turner, C.M. Schuster, et al. 2020. Hyperbaric oxygen treatment following mid-cervical spinal cord injury preserves diaphragm muscle function. International Journal of Molecular Sciences 21 (19): 7219.PubMedPubMedCentralCrossRef Smuder, A.J., S.M. Turner, C.M. Schuster, et al. 2020. Hyperbaric oxygen treatment following mid-cervical spinal cord injury preserves diaphragm muscle function. International Journal of Molecular Sciences 21 (19): 7219.PubMedPubMedCentralCrossRef
41.
go back to reference Gorgey, A.S., O. Witt, L. O’Brien, et al. 2019. Mitochondrial health and muscle plasticity after spinal cord injury. European Journal of Applied Physiology 119 (2): 315–331.PubMedCrossRef Gorgey, A.S., O. Witt, L. O’Brien, et al. 2019. Mitochondrial health and muscle plasticity after spinal cord injury. European Journal of Applied Physiology 119 (2): 315–331.PubMedCrossRef
42.
go back to reference Sandri, M., J. Lin, C. Handschin, et al. 2006. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proceedings of the National Academy of Sciences 103 (44): 16260–16265.CrossRef Sandri, M., J. Lin, C. Handschin, et al. 2006. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proceedings of the National Academy of Sciences 103 (44): 16260–16265.CrossRef
43.
go back to reference Rowe, G.C., S. Raghuram, C. Jang, et al. 2014. PGC-1α induces SPP1 to activate macrophages and orchestrate functional angiogenesis in skeletal muscle. Circulation Research 115 (5): 504–517.PubMedPubMedCentralCrossRef Rowe, G.C., S. Raghuram, C. Jang, et al. 2014. PGC-1α induces SPP1 to activate macrophages and orchestrate functional angiogenesis in skeletal muscle. Circulation Research 115 (5): 504–517.PubMedPubMedCentralCrossRef
44.
go back to reference Hu, J.Z., H. Long, T.D. Wu, et al. 2015. The effect of estrogen-related receptor α on the regulation of angiogenesis after spinal cord injury. Neuroscience 290: 570–580.PubMedCrossRef Hu, J.Z., H. Long, T.D. Wu, et al. 2015. The effect of estrogen-related receptor α on the regulation of angiogenesis after spinal cord injury. Neuroscience 290: 570–580.PubMedCrossRef
45.
go back to reference Higashino, K., T. Matsuura, K. Suganuma, et al. 2013. Early changes in muscle atrophy and muscle fiber type conversion after spinal cord transection and peripheral nerve transection in rats. Journal of Neuroengineering and Rehabilitation 10: 46.PubMedPubMedCentralCrossRef Higashino, K., T. Matsuura, K. Suganuma, et al. 2013. Early changes in muscle atrophy and muscle fiber type conversion after spinal cord transection and peripheral nerve transection in rats. Journal of Neuroengineering and Rehabilitation 10: 46.PubMedPubMedCentralCrossRef
46.
go back to reference Marzetti, E., R. Calvani, M. Cesari, et al. 2013. Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. International Journal of Biochemistry & Cell Biology 45 (10): 2288–2301.CrossRef Marzetti, E., R. Calvani, M. Cesari, et al. 2013. Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. International Journal of Biochemistry & Cell Biology 45 (10): 2288–2301.CrossRef
47.
go back to reference Scholpa, N.E., E.C. Simmons, D.G. Tilley, et al. 2019. β(2)-adrenergic receptor-mediated mitochondrial biogenesis improves skeletal muscle recovery following spinal cord injury. Experimental Neurology 322: 113064.PubMedPubMedCentralCrossRef Scholpa, N.E., E.C. Simmons, D.G. Tilley, et al. 2019. β(2)-adrenergic receptor-mediated mitochondrial biogenesis improves skeletal muscle recovery following spinal cord injury. Experimental Neurology 322: 113064.PubMedPubMedCentralCrossRef
48.
go back to reference Kumar, P., O.W. Osahon, and R.V. Sekhar. 2022. GlyNAC (glycine and N-acetylcysteine) supplementation in mice increases length of life by correcting glutathione deficiency, oxidative stress, mitochondrial dysfunction, abnormalities in mitophagy and nutrient sensing, and genomic damage. Nutrients 14 (5): 1114.PubMedPubMedCentralCrossRef Kumar, P., O.W. Osahon, and R.V. Sekhar. 2022. GlyNAC (glycine and N-acetylcysteine) supplementation in mice increases length of life by correcting glutathione deficiency, oxidative stress, mitochondrial dysfunction, abnormalities in mitophagy and nutrient sensing, and genomic damage. Nutrients 14 (5): 1114.PubMedPubMedCentralCrossRef
Metadata
Title
The Effect of Glycine and N-Acetylcysteine on Oxidative Stress in the Spinal Cord and Skeletal Muscle After Spinal Cord Injury
Authors
Xin Xu
Chun-Jia Zhang
Zuliyaer Talifu
Wu-Bo Liu
Ze-Hui Li
Xiao-Xin Wang
Hua-Yong Du
Han Ke
De-Gang Yang
Feng Gao
Liang-Jie Du
Yan Yu
Ying-Li Jing
Jian-Jun Li
Publication date
17-11-2023
Publisher
Springer US
Keyword
Acetylcysteine
Published in
Inflammation / Issue 2/2024
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-023-01929-9

Other articles of this Issue 2/2024

Inflammation 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.